Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Transplant for Older AML Patients in First Remission
NCT00070135Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 2004
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan in acute myeloid leukemia (AML), sponsored by Cancer and Leukemia Group B. Started Jan 2004; status: completed.
02
Drugs
fludarabinebusulfan
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00070135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070135.